Dr. Steffen Oppenländer

Primary Focus & Experience

Steffen represents private equity and corporate clients on complex domestic and cross-border acquisitions, public takeovers and take privates, minority investments and joint ventures. Steffen is Managing Partner of the Munich office.

Selected Projects

• Bain Capital on acquisition of Wittur Group and Wittur on acquisition of Sematic Group.
• BBA Capital, Athos and Bitburger on the acquisition of Schülke
• CVC Capital on sale of Flint Group.
• EQT X on the public takeover of va-Q-tec and on a majority investment in Acronis AG.
• EQT IX on the public takeover and take private of zooplus.
• EQT IX on the acquisition of thinkproject.
• EQT VIII on the acquisition of SUSE, the subsequent acquisition of Rancher by SUSE and the delisting of SUSE.
• EQT VIII on its acquisition of a minority participation in Ottobock.
• EQT Future on the acquisition of Anticimex and the investment in Flix SE.
• EQT Mid Market on the sale of BBS Automation.
• Founder of SHL Medical on the sale of a minority participation to EQT.
• GS PIA on material undisclosed investment and divestment.
• Hg Capital on its investment in GGW.
• Moonfare on capital investments by Fidelity and Insight Partners.
• OTPP and PAI on the acquisition of Veonet.
• PAI on the acquisition of zahneins.

Recognition & Accomplishments

Steffen is recognized as one of the leading lawyers in Germany for private equity and M&A, including by directories JUVE, Chambers and Legal 500. Prior to joining Milbank in 2017, Steffen was a partner at Hengeler Mueller, where he started his career in 2003.